6 – 7 May 2016 | New York, NY

  • 10.25


  • myCME
6 – 7 May 2016 | The Roosevelt Hotel, New York City

5th Annual CME Symposium

This advanced continuing medical education activity, taking place at the historic Roosevelt Hotel in midtown Manhattan, New York, will provide participants with state-of-the-art education and practical guidance from nationally and internationally recognized experts on hepatitis C virus infection.

The primary goals of this activity are to increase each attendee's competence to:

  • •  Recognize the indications for HCV treatment and delineate therapeutic options for treatment
  • •  Distinguish options for disease staging in patients with hepatitis C
  • •  Explain barriers to effective care of patients with hepatitis C
  • •  Apply new information to manage disease in difficult-to-treat populations
  • •  Recognize conditions for development of resistance to antiviral therapy
  • •  Illustrate possible treatment interactions with other drug therapies and issues affecting drug metabolism
  • •  Identify viral targets of current and new therapies

As we enter the fifth year of HEPATITIS C MANAGEMENT – STATE OF THE ART, enormous progress continues to be made in the treatment of this disease. A rapidly increasing number of treatment options require practitioners to continually update their knowledge about the potential benefits and pharmacology of various hepatitis C therapies. These therapies, as well as their side effects and effectiveness, make the decision to treat individual patients more complex. They require the practitioner to possess a sophisticated understanding of the natural history of the disease, viral resistance to therapy, and management requirements of various patient populations with hepatitis C.

Target Audience

The state-of-the art curriculum offered at this activity is designed to meet the needs of hepatologists, gastroenterologists, infectious disease specialists, general practitioners, physician assistants, nurse practitioners, registered nurses, pharmacists and other frontline healthcare professionals involved in the management of patients with hepatitis C, including those with HCV/HIV coinfection.